Literature DB >> 14513338

[The symptom sympathetic maintained pain].

J Schattschneider1, G Wasner, A Binder, D Siebrecht, R Baron.   

Abstract

Sympathetically maintained pain is a symptom which occurs in neuropathic pain syndromes of different etiologies. From animal experiments it is known that nociceptive afferents after partial nerve lesions develop adrenergic sensitivity at the site of the injury. In addition, a sympathetic-afferent coupling takes place in the dorsal root ganglia. It is still controversial if these pathophysiological mechanisms are responsible for the developing of SMP in humans. Clinical studies support the idea that also in humans the application of adrenergic substances in pharmacological doses is capable to influence nociception, but a direct interaction between the sympathetic system and the nociceptive system had not been demonstrated so far. By using a thermal suit for whole body cooling and warming, which produces low and high activity of sympathetic vasoconstrictor neurons, it was possible for the first time to demonstrate an interaction between physiological changes in sympathetic activity and nociception.

Entities:  

Mesh:

Year:  2003        PMID: 14513338     DOI: 10.1007/s00482-003-0229-7

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  21 in total

1.  Surgery on the affected upper extremity of patients with a history of complex regional pain syndrome: a retrospective study of 100 patients.

Authors:  S S Reuben; E A Rosenthal; R B Steinberg
Journal:  J Hand Surg Am       Date:  2000-11       Impact factor: 2.230

2.  alpha 1-adrenoceptors in normal and hyperalgesic human skin.

Authors:  P D Drummond; S Skipworth; P M Finch
Journal:  Clin Sci (Lond)       Date:  1996-07       Impact factor: 6.124

3.  Thermoregulatory and rhythm-generating mechanisms governing the sudomotor and vasoconstrictor outflow in human cutaneous nerves.

Authors:  G Bini; K E Hagbarth; P Hynninen; B G Wallin
Journal:  J Physiol       Date:  1980-09       Impact factor: 5.182

4.  Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value.

Authors:  G Wasner; J Schattschneider; K Heckmann; C Maier; R Baron
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

5.  Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia.

Authors:  T S Shi; U Winzer-Serhan; F Leslie; T Hökfelt
Journal:  Pain       Date:  2000-02       Impact factor: 6.961

Review 6.  Reflex sympathetic dystrophy: changing concepts and taxonomy.

Authors:  M Stanton-Hicks; W Jänig; S Hassenbusch; J D Haddox; R Boas; P Wilson
Journal:  Pain       Date:  1995-10       Impact factor: 6.961

7.  Noradrenaline-evoked pain in neuralgia.

Authors:  Erik Torebjörk; LisKarin Wahren; Gunnar Wallin; Rolf Hallin; Martin Koltzenburg
Journal:  Pain       Date:  1995-10       Impact factor: 6.961

8.  Spontaneous impulse generation in normal and denervated dorsal root ganglia: sensitivity to alpha-adrenergic stimulation and hypoxia.

Authors:  K J Burchiel
Journal:  Exp Neurol       Date:  1984-08       Impact factor: 5.330

Review 9.  Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study.

Authors:  A R Jadad; D Carroll; C J Glynn; H J McQuay
Journal:  J Pain Symptom Manage       Date:  1995-01       Impact factor: 3.612

10.  Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients.

Authors:  D D Price; S Long; B Wilsey; A Rafii
Journal:  Clin J Pain       Date:  1998-09       Impact factor: 3.442

View more
  2 in total

1.  [Neuropathic and tumour-induced headache: Therapeutic options].

Authors:  A Wagner; J A Blunk; J Benrath
Journal:  HNO       Date:  2011-07       Impact factor: 1.284

2.  Patient satisfaction of primary care for musculoskeletal diseases: a comparison between Neural Therapy and conventional medicine.

Authors:  Joelle Mermod; Lorenz Fischer; Lukas Staub; André Busato
Journal:  BMC Complement Altern Med       Date:  2008-06-24       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.